European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer.
暂无分享,去创建一个
Suresh Senan | Corinne Faivre-Finn | Ursula Nestle | Dirk De Ruysscher | Allan Price | D. de Ruysscher | C. Faivre-Finn | S. Senan | A. Price | U. Nestle | C. Hurkmans | C. Le Péchoux | Coen W Hurkmans | Cécile Le Péchoux
[1] D. de Ruysscher,et al. Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy. , 2012, Cancer treatment reviews.
[2] Jinzhong Yang,et al. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. , 2011, International journal of radiation oncology, biology, physics.
[3] Hans-Ulrich Kauczor,et al. MRI of the lung: state of the art. , 2012, Diagnostic and interventional radiology.
[4] Philippe Giraud,et al. Respiratory Gating Techniques for Optimization of Lung Cancer Radiotherapy , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] Anton Mans,et al. Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques. , 2011, International journal of radiation oncology, biology, physics.
[6] C. Le Péchoux,et al. Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. , 2011, The oncologist.
[7] P. Lambin,et al. Volume or position changes of primary lung tumor during (chemo-)radiotherapy cannot be used as a surrogate for mediastinal lymph node changes: the case for optimal mediastinal lymph node imaging during radiotherapy. , 2011, International journal of radiation oncology, biology, physics.
[8] Geoffrey D. Hugo,et al. Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[9] Matthias Guckenberger,et al. Feasibility study for markerless tracking of lung tumors in stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[10] J. Petersen,et al. Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung , 2010, Acta oncologica.
[11] Lone Hoffmann,et al. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients , 2010, Acta oncologica.
[12] J. Sonke,et al. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters. , 2010, International journal of radiation oncology, biology, physics.
[13] P. Lambin,et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. , 2010, International journal of radiation oncology, biology, physics.
[14] Jose Belderbos,et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Alfons G H Kessels,et al. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] Jan-Jakob Sonke,et al. Adaptive radiotherapy for lung cancer. , 2010, Seminars in radiation oncology.
[17] D. Lacombe,et al. EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] D. de Ruysscher,et al. Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study. , 2010, International journal of radiation oncology, biology, physics.
[19] Philippe Lambin,et al. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Radhe Mohan,et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[21] Ke Sheng,et al. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[22] Joseph O Deasy,et al. Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects. , 2010, International journal of radiation oncology, biology, physics.
[23] Joseph O Deasy,et al. The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. , 2010, International journal of radiation oncology, biology, physics.
[24] Adam P Dicker,et al. Radiation dose-volume effects in the brain. , 2010, International journal of radiation oncology, biology, physics.
[25] Joseph O. Deasy,et al. Radiation dose-volume effects in the esophagus. , 2010, International journal of radiation oncology, biology, physics.
[26] K. Brock,et al. Accurate accumulation of dose for improved understanding of radiation effects in normal tissue. , 2010, International Journal of Radiation Oncology, Biology, Physics.
[27] Joseph O Deasy,et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. , 2010, International journal of radiation oncology, biology, physics.
[28] M. Martel,et al. Radiation dose-volume effects in the lung. , 2010, International journal of radiation oncology, biology, physics.
[29] E. Yorke,et al. Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.
[30] T. Schultheiss,et al. Radiation dose-volume effects in the spinal cord. , 2010, International journal of radiation oncology, biology, physics.
[31] L. Baddour,et al. Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] Peter A S Johnstone,et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[33] Ursula Nestle,et al. Nonrigid Versus Rigid Registration of Thoracic 18F-FDG PET and CT in Patients with Lung Cancer: An Intraindividual Comparison of Different Breathing Maneuvers , 2009, Journal of Nuclear Medicine.
[34] Jan-Jakob Sonke,et al. Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography. , 2009, International journal of radiation oncology, biology, physics.
[35] S. Senan,et al. Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] L. Goldman,et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) (European Respiratory Journal (2009) 34 (17-41)) , 2009 .
[37] A. Grosu,et al. How to use functional imaging information for radiotherapy planning. , 2009, European journal of cancer.
[38] Jonathan G. Li,et al. Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. , 2009, International journal of radiation oncology, biology, physics.
[39] Jan-Jakob Sonke,et al. Effects of respiration-induced density variations on dose distributions in radiotherapy of lung cancer. , 2009, International journal of radiation oncology, biology, physics.
[40] Jan Nyman,et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] C. Villarreal-Garza,et al. High Frequency of Radiation Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Concurrent Radiotherapy and Gemcitabine after Induction with Gemcitabine and Carboplatin , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[42] C. Reddy,et al. Comprehensive Analysis of Pulmonary Function Test (PFT) Changes After Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer in Medically Inoperable Patients , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[43] Colin G Orton,et al. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2009, Medical physics.
[44] L. Goldman,et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) , 2009, European Respiratory Journal.
[45] Jan-Jakob Sonke,et al. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. , 2009, International journal of radiation oncology, biology, physics.
[46] Shipeng Yu,et al. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[47] Elinore Wieslander,et al. The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: implications for tumour coverage. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[48] Jan Nyman,et al. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[49] Yuta Shibamoto,et al. Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results , 2009, Radiation oncology.
[50] Wolfgang A Weber,et al. Assessing Tumor Response to Therapy , 2009, Journal of Nuclear Medicine.
[51] Suresh Senan,et al. Radiotherapy for lung cancer: clinical impact of recent technical advances. , 2009, Lung cancer.
[52] Jane Higgins,et al. Comparison of spine, carina, and tumor as registration landmarks for volumetric image-guided lung radiotherapy. , 2009, International journal of radiation oncology, biology, physics.
[53] S. Senan,et al. Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy , 2009, Cancer.
[54] Joachim Widder,et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study , 2009, Radiation oncology.
[55] S. Ben-Haim,et al. 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response* , 2008, Journal of Nuclear Medicine.
[56] Suresh Senan,et al. Motion analysis of 100 mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive strategies. , 2008, International journal of radiation oncology, biology, physics.
[57] J. Galvin,et al. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[58] D. Hellwig,et al. FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer , 2009, Nuklearmedizin.
[59] Cynthia S. Johnson,et al. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] Carri K Glide-Hurst,et al. A simplified method of four-dimensional dose accumulation using the mean patient density representation. , 2008, Medical physics.
[61] E. Kunieda,et al. Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing , 2008, Radiation Medicine.
[62] Lawrence B Marks,et al. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2008, Seminars in radiation oncology.
[63] C. Yiannoutsos,et al. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[64] B. Jeremic,et al. Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC). , 2008, International journal of radiation oncology, biology, physics.
[65] P. Lambin,et al. Transition from a simple to a more advanced dose calculation algorithm for radiotherapy of non-small cell lung cancer (NSCLC): implications for clinical implementation in an individualized dose-escalation protocol. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[66] W. Oyen,et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[67] C. Hurkmans,et al. Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose , 2008, Radiation oncology.
[68] T. Teshima,et al. Changes in patterns of care for limited-stage small-cell lung cancer: results of the 99-01 patterns of care study-a nationwide survey in Japan. , 2008, International journal of radiation oncology, biology, physics.
[69] J. Crowley,et al. Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] P. Lambin,et al. HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[71] Geoffrey G. Zhang,et al. Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. , 2008, International journal of radiation oncology, biology, physics.
[72] James Bedford,et al. Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[73] Jan-Jakob Sonke,et al. Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients. , 2008, International journal of radiation oncology, biology, physics.
[74] E. Smit,et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[75] Geoffrey D Hugo,et al. Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography. , 2008, International journal of radiation oncology, biology, physics.
[76] Peter C Levendag,et al. Time dependence of intrafraction patient motion assessed by repeat stereoscopic imaging. , 2008, International journal of radiation oncology, biology, physics.
[77] On-line image guidance for frameless stereotactic radiotherapy of lung malignancies by cone beam CT: Comparison between target localization and alignment on bony anatomy , 2008, Acta oncologica.
[78] P. Lambin,et al. Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[79] Radiation oncology advances: an introduction. , 2008, Cancer treatment and research.
[80] Tommy Knöös,et al. Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[81] Marjan A Admiraal,et al. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[82] S. Ryu,et al. Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer - tumor motion and using internal target volume (ITV) could improve dose distribution in CTV. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[83] Wei Lu,et al. Assessment of intrafraction mediastinal and hilar lymph node movement and comparison to lung tumor motion using four-dimensional CT. , 2007, International journal of radiation oncology, biology, physics.
[84] T. Krieger,et al. Four-dimensional treatment planning for stereotactic body radiotherapy. , 2007, International journal of radiation oncology, biology, physics.
[85] P. Lambin,et al. Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials. , 2007, Cancer treatment reviews.
[86] K. Ohtomo,et al. Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors , 2007, Radiation oncology.
[87] Jan-Jakob Sonke,et al. Kilo-voltage cone-beam computed tomography setup measurements for lung cancer patients; first clinical results and comparison with electronic portal-imaging device. , 2007, International journal of radiation oncology, biology, physics.
[88] George Starkschall,et al. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[89] P. Lambin,et al. Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[90] B. Jeremic,et al. Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey. , 2007, Lung cancer.
[91] David A Jaffray,et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position. , 2007, International journal of radiation oncology, biology, physics.
[92] Matthias Guckenberger,et al. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[93] S. Senan,et al. Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer? , 2007, International journal of radiation oncology, biology, physics.
[94] E. Dieleman,et al. Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. , 2007, International journal of radiation oncology, biology, physics.
[95] Jinming Yu,et al. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[96] George Starkschall,et al. Assessment of lung tumor motion and setup uncertainties using implanted fiducials. , 2007, International journal of radiation oncology, biology, physics.
[97] Current practice when treating lung cancer in Australasia. , 2007, Australasian radiology.
[98] Luca Cozzi,et al. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations , 2006, Physics in medicine and biology.
[99] Philippe Lambin,et al. Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study. , 2006, International journal of radiation oncology, biology, physics.
[100] Ursula Nestle,et al. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[101] Lech Papiez,et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[102] Steve B. Jiang,et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. , 2006, Medical physics.
[103] J. Lebesque,et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[104] P. Lambin,et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[105] B. Heijmen,et al. Limitations of the planning organ at risk volume (PRV) concept. , 2006, International journal of radiation oncology, biology, physics.
[106] N. Viñolas,et al. Spanish patterns of care for 3D radiotherapy in non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.
[107] Suresh Senan,et al. 4D imaging for target definition in stereotactic radiotherapy for lung cancer , 2006, Acta oncologica.
[108] Matthias Guckenberger,et al. Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors , 2006, Acta oncologica.
[109] Hak Choy,et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer , 2006, Acta oncologica.
[110] P C Levendag,et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results , 2006, Acta oncologica.
[111] S. Marnitz,et al. Value of 18F-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy , 2006, Clinical Cancer Research.
[112] Philippe Lambin,et al. An "in silico" clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[113] G. Guyatt,et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.
[114] Patrick A Kupelian,et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment. , 2005, International journal of radiation oncology, biology, physics.
[115] Suresh Senan,et al. Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. , 2005, International journal of radiation oncology, biology, physics.
[116] J. Daurès,et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[117] Randall K Ten Haken,et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. , 2005, International journal of radiation oncology, biology, physics.
[118] Philippe Lambin,et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. , 2005, International journal of radiation oncology, biology, physics.
[119] Suresh Senan,et al. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. , 2005, International journal of radiation oncology, biology, physics.
[120] C. Ling,et al. Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma , 2005, Cancer.
[121] M. Socinski,et al. Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer? , 2005, International journal of radiation oncology, biology, physics.
[122] M. Herk. Errors and margins in radiotherapy. , 2004 .
[123] J. Jett,et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[124] M. Schwaiger,et al. Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[125] L. Broemeling,et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[126] H. Groen,et al. A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[127] Danny Rischin,et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[128] Suresh Senan,et al. Procedures for high precision setup verification and correction of lung cancer patients using CT-simulation and digitally reconstructed radiographs (DRR). , 2003, International journal of radiation oncology, biology, physics.
[129] P. Voet,et al. Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)? , 2002, Lung cancer.
[130] N. Saijo,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[131] M. V. van Herk,et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.
[132] Marcel van Herk,et al. Margins for geometric uncertainty around organs at risk in radiotherapy. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[133] J. Herndon,et al. Therapy choices among older patients with lung carcinoma , 2002, Cancer.
[134] O. Holmberg,et al. Impact of intravenous contrast on target definition in radiotherapy of non small cell lung cancer , 2001 .
[135] R K Ten Haken,et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[136] J C Rosenwald,et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.
[137] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[138] R. Ginsberg,et al. Induction therapy for stage III NSCLC: a consensus report. , 1994, Lung cancer.
[139] Icru. Prescribing, recording, and reporting photon beam therapy , 1993 .
[140] K M Harris,et al. The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings. , 1993, Clinical radiology.
[141] S Sone,et al. The number and size of normal mediastinal lymph nodes: a postmortem study. , 1988, AJR. American journal of roentgenology.
[142] F L Bookstein,et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. , 1985, AJR. American journal of roentgenology.